ALK in digital venture for direct contact with allergy sufferers
When the allergy and immunotherapy company ALK presented its annual report recently, it was based on the company's new growth strategy, which was presented to the public in December last year by CEO Carsten Hellmann.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
ALK to spend millions on US launch
For abonnenter
ALK CEO: We must hit it out of the park
For abonnenter
Merck: We want to expand the partnership with ALK
For abonnenter